James George to Chronic Disease
This is a "connection" page, showing publications James George has written about Chronic Disease.
Connection Strength
0.382
-
Complete remission of refractory immune thrombocytopenia (ITP) with a short course of Romiplostim. Eur J Haematol. 2013 Oct; 91(4):376-7.
Score: 0.102
-
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol. 2009 Feb; 144(3):409-15.
Score: 0.073
-
Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura. Int J Hematol. 2005 Feb; 81(2):119-25.
Score: 0.056
-
Occult recurrent breast cancer masquerading as thrombotic thrombocytopenic purpura. Am J Hematol. 2023 May; 98(5):830-832.
Score: 0.048
-
Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Semin Hematol. 2000 Jul; 37(3):290-8.
Score: 0.041
-
Chronic idiopathic thrombocytopenic purpura. N Engl J Med. 1994 Nov 03; 331(18):1207-11.
Score: 0.028
-
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes. 2008 Feb 08; 6:13.
Score: 0.017
-
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008 Feb 02; 371(9610):395-403.
Score: 0.017